Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Genetic Mutation and Outcome of Venetoclax-Based Therapy in Newly Diagnosed AML in the Real World: Hokkaido Leukemia Net Study

Blood (2023) 142 (Supplement 1): 1470.

https://doi.org/10.1182/blood-2023-173909

Published: 2023

Journal Articles

Addition of High-Dose Methotrexate to Initial Chemotherapy Improved Treatment Outcome of Patients with Newly Diagnosed Intravascular Large B-Cell Lymphoma: A Multicenter, Retrospective Study

Blood (2023) 142 (Supplement 1): 440.

https://doi.org/10.1182/blood-2023-181183

Published: 2023

Journal Articles

Baseline 18 f-Fluorodeoxyglucose PET/CT Radiomics Predicts Outcome in Newly Diagnosed Intravascular Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 6321.

https://doi.org/10.1182/blood-2023-188507

Published: 2023

Journal Articles

Incidentally Detected Complex Karyotypic Abnormalities in the Bone Marrow Provide a Clue to Diagnosing Intravascular Large B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 790–791.

https://doi.org/10.1182/blood-2022-169519

Published: 2022

Journal Articles

Novel Simple Prognostic Index (NJHSG-PI) Can Effectively Predict Prognosis in Patients with Newly Diagnosed DLBCL : A Real World Analysis across 14 Cancer Centers in Japan

Koh Izumiyama, Shinpei Harada, Hajime Senjo, Reiki Ogasawara, Tomoyuki Saga, Tetsuyuki Igarashi, Kentaro Wakasa, Ikumi Kasahara, Yukari Takeda, Keisuke Yamaguchi, Akio Shigematsu, Mutsumi Takahata, Katsuya Fujimoto, Yoshihito Haseyama, Takahiro Nagashima, Hajime Sakai, Yasutaka Kakinoki, Mitsutoshi Kurosawa, Takanori Teshima

Blood (2022) 140 (Supplement 1): 782–784.

https://doi.org/10.1182/blood-2022-165038

Published: 2022

Journal Articles

Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3210–3211.

https://doi.org/10.1182/blood-2022-157874

Published: 2022

Journal Articles

Subclinical Minute FLT3 -ITD Clone Can be Detected in Clinically FLT3 -ITD-Negative Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 9094–9095.

https://doi.org/10.1182/blood-2022-162325

Published: 2022

Journal Articles

Elevated FDG Uptake in the Lung Is a Characteristic Finding of Intravascular Large B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 6713–6714.

https://doi.org/10.1182/blood-2022-169208

Published: 2022

Journal Articles

Prognostic Significance of Cytogenetic Abnormalities for Patients with Acute Lymphoblastic Leukemia, a Region-Wide Retrospective Study

Blood (2019) 134 (Supplement_1): 5202.

https://doi.org/10.1182/blood-2019-125084

Published: 2019

Journal Articles

The Efficacy and Long-Term Outcomes of ASCT in POEMS Syndrome: A Multicenter Retrospective Study in Japan

Chika Kawajiri, MD, Emiko Sakaida, MD PhD, Chikako Ohwada, MD PhD, Toshihiro Miyamoto, MD PhD, Taichi Azuma, MDPhD, Jun Taguchi, MD PhD, Takehiko Mori, MD PhD, Yuichi Hasegawa, MD PhD, Tadakazu Kondo, MD PhD, Toshiaki Yujiri, MD PhD, Makoto Yoshimitsu, MDPhD, Mitsuru Tsudo, Toshihiko Iwasaki, MD PhD, Akio Shigematsu, MD PhD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MDPhD, Makoto Hirokawa, MD PhD, Hisashi Sakamaki, MDPhD, Chiaki Nakaseko, MD PhD

Blood (2014) 124 (21): 3970.

https://doi.org/10.1182/blood.V124.21.3970.3970

Published: 2014

Journal Articles

Phase II Trial Of Medium-Dose VP-16, Cyclophosphamide and Total-Body Irradiation Conditioning Regimen Before Allogeneic Stem Cell Transplantation For Acute Lymphoblastic Leukemia In Adults

Tatsunori Goto, MD, Akio Shigematsu, MD, PhD, Makoto Onizuka, MD, PhD, Shin Fujisawa, MD, Ritsuro Suzuki, MD, Yoshiko Atsuta, MD, Kazuo Hatanaka, MD, Masayoshi Masuko, MD, PhD, Toshiro Ito, MD, PhD, Naoki Kobayashi, MD, PhD, Jun Kato, MD, Koichi Miyamura, MD, PhD, Takahiro Fukuda, MD, Yasuo Morishima, Masahiro Imamura, MD, PhD

Blood (2013) 122 (21): 544.

https://doi.org/10.1182/blood.V122.21.544.544

Published: 2013

Journal Articles

Role of Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia in an HTLV-1 Non-Endemic Area of Japan.

Akio Shigematsu, MD, PhD, Junji Tanaka, MD, PhD, Naoki Kobayashi, MD, PhD, Hiroshi Yasui, MD, PhD, Motohiro Shindo, MD, PhD, Yasutaka Kakinoki, MD, PhD, Kakinoki Yasutaka, MD, PhD, Satoshi Iyama, MD, PhD, Kuroda HIroyuki, MD, PhD, Tsutsumi Yutaka, MD.PhD, Satoshi Hashino, MD, PhD, Masahiro Imamura, MD, PhD, Takanori Teshima, MD, PhD

Blood (2012) 120 (21): 3089.

https://doi.org/10.1182/blood.V120.21.3089.3089

Published: 2012

Journal Articles

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Mitsufumi Nishio, MD, PhD, Satoshi Yamamoto, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Toshiya Sakai, MD, PhD, Takeshi Kondo, MD, PhD, Akio Shigematsu, MD, PhD, Junichi Sugita, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, M.D., Masahiro Imamura, MD, PhD, Takanori Teshima, MD, PhD

Blood (2012) 120 (21): 4544.

https://doi.org/10.1182/blood.V120.21.4544.4544

Published: 2012

Journal Articles

Dasatinib enhances the expansion of CD56 + CD3 − NK cells from cord blood

Junji Tanaka, Junichi Sugita, Souichi Shiratori, Akio Shigematsu, Masahiro Imamura

Blood (2012) 119 (25): 6175–6176.

https://doi.org/10.1182/blood-2012-03-416800

Published: 2012

Journal Articles

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Minauchi Koichiro, MD, Akio Shigematsu, MD, PhD, Masanobu Nakata, MD, Toshihiro Matsukawa, MD, Koh Ebata, MD, Tomohiro Yamakawa, MD, Tomoyuki Saga, MD, Kanako Shima, MD, Makoto Ibata, MD, PhD, Junichi Sugita, MD, PhD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Masahiro Ogasawara, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Imamura, MD, PhD, Naoki Kobayashi, MD, Ph.D

Blood (2011) 118 (21): 4154.

https://doi.org/10.1182/blood.V118.21.4154.4154

Published: 2011

Journal Articles

Outcome After First Relapse In Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Shinichi Kako, MD, Heiwa Kanamori, MD, Naoki Kobayashi, MD, Akio Shigematsu, MD, Yasuhito Nannya, MD, Mika Nakamae, M.D., Ph.D, Kazuyuki Shigeno, MD, Kazumi Suzukawa, MD, Masahiro Takeuchi, MD, Motohiro Tsuzuki, MD, Kensuke Usuki, MD, Kazuo Hatanaka, MD, Kazuei Ogawa, MD, Kinuko Mitani, MD, Yuichiro Nawa, MD, Yoshihiro Hatta, MD, Ishikazu Mizuno, MD, Yoshinobu Kanda, MD

Blood (2011) 118 (21): 3084.

https://doi.org/10.1182/blood.V118.21.3084.3084

Published: 2011

Journal Articles

Superior Outcomes Using Medium-Dose VP-16/CY/TBI to CY/TBI as a Conditioning Regimen for Allogeneic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia.

Akio Shigematsu, MD, PhD, Junji Tanaka, MD, PhD, Ritsuro Suzuki, MD, PhD, Takakazu Kawase, MD, PhD, Hideki Akiyama, Takahiro Fukuda, Keiki Kumano, MD, PhD, Fumiaki Yoshiba, Heiwa Kanamori, Naoki Kobayashi, Takashi Fukuhara, Masahiro Imamura, MD, PhD

Blood (2009) 114 (22): 2306.

https://doi.org/10.1182/blood.V114.22.2306.2306

Published: 2009

Journal Articles

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Mitsufumi Nishio, MD, PhD, Kohki Kumano, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Tomoyuki Endo, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Akio Shigematsu, MD, PhD, Takeshi Kondo, MD., PhD, Junji Tanaka, MD, PhD, Satoshi Hashino, Masahiro Imamura, Hiroshi Nishihara, M.D., Ph.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 1476.

https://doi.org/10.1182/blood.V112.11.1476.1476

Published: 2008

Journal Articles

Analysis of TREC (T Cell Receptor Excision Circles) Levels in CD94 Expressing CD8 T Cells in Chronic GVHD.

Noriaki Iwao, MD, Junji Tanaka, MD, Naoko Kato, MD, Takeshi Kondo, MD, Yoko Miura, MD, Tomomi Toubai, MD, Akio Shigematsu, MD, Keiichi Kondo, MD, Shuichi Ohta, MD, Masahiro Asaka, MD, Masahiro Imamura, MD

Blood (2005) 106 (11): 5367.

https://doi.org/10.1182/blood.V106.11.5367.5367

Published: 2005

Journal Articles

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing CD8 T Cells from Various Blood Mononuclear Cells with Cytolytic Activity Against Primary Leukemic Cells.

Junji Tanaka, MD, Noriaki Iwao, MD, Tomomi Toubai, MD, Yoko Miura, MD, Naoko Kato, MD, Akio Shigematsu, MD, Keichi Kondo, MD, Shuichi Ota, MD, Masahiro Asaka, MD, Masahiro Imamura, MD

Blood (2004) 104 (11): 4967.

https://doi.org/10.1182/blood.V104.11.4967.4967

Published: 2004

NARROW

Genetic Mutation and Outcome of Venetoclax-Based Therapy in Newly Diagnosed AML in the Real World: Hokkaido Leukemia Net Study

Addition of High-Dose Methotrexate to Initial Chemotherapy Improved Treatment Outcome of Patients with Newly Diagnosed Intravascular Large B-Cell Lymphoma: A Multicenter, Retrospective Study

Baseline 18 f-Fluorodeoxyglucose PET/CT Radiomics Predicts Outcome in Newly Diagnosed Intravascular Large B-Cell Lymphoma

Incidentally Detected Complex Karyotypic Abnormalities in the Bone Marrow Provide a Clue to Diagnosing Intravascular Large B-Cell Lymphoma

Novel Simple Prognostic Index (NJHSG-PI) Can Effectively Predict Prognosis in Patients with Newly Diagnosed DLBCL : A Real World Analysis across 14 Cancer Centers in Japan

Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia

Subclinical Minute FLT3 -ITD Clone Can be Detected in Clinically FLT3 -ITD-Negative Acute Myeloid Leukemia

Elevated FDG Uptake in the Lung Is a Characteristic Finding of Intravascular Large B-Cell Lymphoma

Prognostic Significance of Cytogenetic Abnormalities for Patients with Acute Lymphoblastic Leukemia, a Region-Wide Retrospective Study

The Efficacy and Long-Term Outcomes of ASCT in POEMS Syndrome: A Multicenter Retrospective Study in Japan

Phase II Trial Of Medium-Dose VP-16, Cyclophosphamide and Total-Body Irradiation Conditioning Regimen Before Allogeneic Stem Cell Transplantation For Acute Lymphoblastic Leukemia In Adults

Role of Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia in an HTLV-1 Non-Endemic Area of Japan.

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Dasatinib enhances the expansion of CD56 + CD3 − NK cells from cord blood

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Outcome After First Relapse In Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Superior Outcomes Using Medium-Dose VP-16/CY/TBI to CY/TBI as a Conditioning Regimen for Allogeneic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia.

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Analysis of TREC (T Cell Receptor Excision Circles) Levels in CD94 Expressing CD8 T Cells in Chronic GVHD.

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing CD8 T Cells from Various Blood Mononuclear Cells with Cytolytic Activity Against Primary Leukemic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only